The latest probe points to challenges for India’s biggest drugmaker after whistle-blower complaints on corporate governance lapses triggered a stock slide last year.
In 2015, billionaire Dilip Shanghvi bought 23% stake for Rs 18 billion, but Suzlon still hasn’t exited India’s debt-restructuring program, missing deadlines since 2017.
The reasons for both sides preventing any escalation lie in the political and military context of the strategic situation in West Asia within the larger global geopolitical framework.
Economists say there are weaknesses in India’s GDP data. But statisticians claim the accusations are based on flawed understanding, saying while GDP has problems, the economists are looking in the wrong places.
Coaching centres for Army aspirants in Jhunjhunu are shutting down due to plummeting admissions in the face of a lack of job guarantees under Agnipath Scheme.
Big Pharma, such as, Johnson and Johnson, Abbott, Purdue that were responsible for causing opioid crisis in USA are shifting their shops to India to peddle their poison here. They are facing immense pressure in US with a slew of court filings and billions in restitution.
Source: https://www.theguardian.com/world/2019/aug/27/india-opioids-crisis-us-pain-narcotics
Big Pharma, such as, Johnson and Johnson, Abbott, Purdue that were responsible for causing opioid crisis in USA are shifting their shops to India to peddle their poison here. They are facing immense pressure in US with a slew of court filings and billions in restitution.
Source: https://www.theguardian.com/world/2019/aug/27/india-opioids-crisis-us-pain-narcotics